scholarly journals Atezolizumab in Japanese Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study

2018 ◽  
Vol 19 (4) ◽  
pp. e405-e415 ◽  
Author(s):  
Toyoaki Hida ◽  
Reiko Kaji ◽  
Miyako Satouchi ◽  
Norihiko Ikeda ◽  
Atsushi Horiike ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Subgroup Analysis ◽  
Japanese Patients ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated

scholarly journals Phase 3 trial comparing nab-paclitaxel with docetaxel for previously treated advanced non–small cell lung cancer

2021 ◽  
Author(s):  
Yasuto Yoneshima ◽  
Satoshi Morita ◽  
Masahiko Ando ◽  
Atsushi Nakamura ◽  
Shunichiro Iwasawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated

scholarly journals KEYNOTE-025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1-positive advanced non-small-cell lung cancer

2019 ◽  
Vol 110 (3) ◽  
pp. 1012-1020 ◽  
Author(s):  
Makoto Nishio ◽  
Toshiaki Takahashi ◽  
Hiroshige Yoshioka ◽  
Kazuhiko Nakagawa ◽  
Tatsuro Fukuhara ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Japanese Patients ◽  
Small Cell ◽  
Small Cell Lung ◽  
Programmed Death Ligand 1 ◽  
Programmed Death ◽  
Previously Treated ◽  
Phase 1B

Subgroup Analysis of Japanese Patients in a Phase III Study of Atezolizumab in Extensive-stage Small-cell Lung Cancer (IMpower133)

2019 ◽  
Vol 20 (6) ◽  
pp. 469-476.e1 ◽  
Author(s):  
Makoto Nishio ◽  
Shunichi Sugawara ◽  
Shinji Atagi ◽  
Hiroaki Akamatsu ◽  
Hiroshi Sakai ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Subgroup Analysis ◽  
Japanese Patients ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Phase Iii Study ◽  
Extensive Stage
Sign in / Sign up

Export Citation Format

Share Document